Nordwand Advisors, LLC Pmv Pharmaceuticals, Inc. Transaction History
Nordwand Advisors, LLC
- $374 Billion
- Q3 2024
A detailed history of Nordwand Advisors, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordwand Advisors, LLC holds 2,000 shares of PMVP stock, worth $3,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$3,220
Previous $3.24 Million
8.02%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
83Shares Held
41.9MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.4 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$5.87 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$5.17 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.23 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.77 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $73.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...